List of insiders holdings for Fulcrum Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2024-09-23 16:15:29 | 0 18,729,099 |
18,729,099 | Form 3 |
2 | LEVIN MARK J Director 10% Owner |
2021-11-12 17:31:37 | 75,800 4,970,625 |
5,046,425 | Form 4 |
3 | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
2020-02-05 16:33:55 | 2,343,154 0 |
2,343,154 | Form 13G |
4 | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner |
2024-02-14 16:19:04 | 2,343,154 0 |
2,343,154 | Form 13G |
5 | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
2024-02-14 16:19:04 | 2,343,154 0 |
2,343,154 | Form 13G |
6 | GLAXOSMITHKLINE PLC 10% Owner |
2021-09-27 06:01:18 | 1,785,714 0 |
1,785,714 | Form 13G |
7 | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli 10% Owner |
2021-02-11 10:23:04 | 1,241,176 0 |
1,241,176 | Form 13G |
8 | Sapir Alex See Remarks |
2025-01-28 16:15:11 | 582,000 0 |
582,000 | Form 4 |
9 | 6 Dimensions Capital L.P. 10% Owner |
2019-07-22 16:32:02 | 559,821 0 |
559,821 | Form 4 |
10 | Sanofi 10% Owner |
2019-07-29 10:13:05 | 558,035 0 |
558,035 | Form 13G |
11 | Section 32 Fund 2 LP Section 32 GP 2 LLC Maris William J 10% Owner |
2019-07-22 16:30:46 | 464,285 0 |
464,285 | Form 4 |
12 | Horn Patrick Taylor Chief Medical Officer |
2024-03-20 16:15:10 | 400,000 0 |
400,000 | Form 4 |
13 | Arroyo Santiago Chief Medical Officer |
2022-11-09 16:15:14 | 400,000 0 |
400,000 | Form 4 |
14 | Stuart Bryan See Remarks |
2022-01-21 16:15:24 | 340,000 0 |
340,000 | Form 4 |
15 | Musso Alan A Chief Financial Officer |
2025-01-28 16:15:14 | 285,000 0 |
285,000 | Form 4 |
16 | Oltmans Curtis Gale Chief Legal Officer |
2025-01-28 16:15:06 | 225,000 0 |
225,000 | Form 4 |
17 | Wallace Owen B. Chief Scientific Officer |
2020-09-14 16:19:08 | 209,030 0 |
209,030 | Form 4 |
18 | Moxham Christopher Chief Scientific Officer |
2021-08-12 16:20:57 | 176,073 0 |
176,073 | Form 4 |
19 | Rajavelu Esther Chief Financial Officer |
2023-02-13 16:15:14 | 160,000 0 |
160,000 | Form 4 |
20 | Dunn Judith See Remarks |
2022-01-21 16:15:31 | 140,890 0 |
140,890 | Form 4 |
21 | Hayes Melvin H. III Chief Operating Officer |
2023-04-28 16:17:16 | 115,000 0 |
115,000 | Form 4 |
22 | Tourangeau Greg Principal Accounting Officer |
2025-01-28 16:15:08 | 76,120 0 |
76,120 | Form 4 |
23 | Cadavid Diego SVP Clinical Development |
2020-07-02 16:19:30 | 65,714 0 |
65,714 | Form 4 |
24 | King Rachel K. Director |
2024-11-14 16:15:03 | 60,000 0 |
60,000 | Form 4 |
25 | Hill Colin Director |
2024-06-18 16:15:04 | 60,000 0 |
60,000 | Form 4 |
26 | Morabito Christopher Chief Medical Officer |
2022-01-21 16:15:17 | 59,744 0 |
59,744 | Form 4 |
27 | Thomson Peter G. VP Finance & Accounting |
2022-01-21 16:15:41 | 40,000 0 |
40,000 | Form 4 |
28 | Dorton Katina Director |
2024-06-18 16:20:07 | 30,000 0 |
30,000 | Form 4 |
29 | GERAGHTY JAMES A Director |
2024-06-18 16:20:09 | 30,000 0 |
30,000 | Form 4 |
30 | Haviland Kate Director |
2024-06-18 16:20:13 | 30,000 0 |
30,000 | Form 4 |
31 | Gould Robert J Director |
2024-06-18 16:20:14 | 30,000 0 |
30,000 | Form 4 |
32 | Ezekowitz Alan Director |
2024-06-18 16:20:20 | 30,000 0 |
30,000 | Form 4 |
33 | Collins James J. Director |
2024-06-18 16:20:06 | 30,000 0 |
30,000 | Form 4 |
34 | Banks Sonja Director |
2024-06-18 16:20:03 | 30,000 0 |
30,000 | Form 4 |